Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2024 | REGN

Regeneron Pharmaceuticals total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Regeneron Pharmaceuticals total liabilities and share holders equity for the quarter ending September 30, 2024 was $37.442B, a 16.41% increase year-over-year.
  • Regeneron Pharmaceuticals total liabilities and share holders equity for 2023 was $33.08B, a 13.23% increase from 2022.
  • Regeneron Pharmaceuticals total liabilities and share holders equity for 2022 was $29.215B, a 14.86% increase from 2021.
  • Regeneron Pharmaceuticals total liabilities and share holders equity for 2021 was $25.435B, a 48.19% increase from 2020.
  
Regeneron Pharmaceuticals Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $33,080
2022 $29,215
2021 $25,435
2020 $17,163
2019 $14,805
2018 $11,735
2017 $8,764
2016 $6,973
2015 $5,609
2014 $3,838
2013 $2,951
2012 $2,080
2011 $1,324
2010 $1,089
2009 $741
Regeneron Pharmaceuticals Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $37,442
2024-06-30 $36,087
2024-03-31 $34,370
2023-12-31 $33,080
2023-09-30 $32,163
2023-06-30 $30,658
2023-03-31 $30,060
2022-12-31 $29,215
2022-09-30 $27,678
2022-06-30 $27,206
2022-03-31 $26,349
2021-12-31 $25,435
2021-09-30 $23,672
2021-06-30 $21,486
2021-03-31 $17,772
2020-12-31 $17,163
2020-09-30 $16,084
2020-06-30 $14,429
2020-03-31 $15,758
2019-12-31 $14,805
2019-09-30 $13,939
2019-06-30 $13,174
2019-03-31 $12,855
2018-12-31 $11,735
2018-09-30 $10,806
2018-06-30 $9,952
2018-03-31 $9,373
2017-12-31 $8,764
2017-09-30 $8,701
2017-06-30 $8,106
2017-03-31 $7,817
2016-12-31 $6,973
2016-09-30 $6,828
2016-06-30 $6,205
2016-03-31 $5,904
2015-12-31 $5,609
2015-09-30 $5,183
2015-06-30 $4,527
2015-03-31 $4,199
2014-12-31 $3,838
2014-09-30 $3,739
2014-06-30 $3,456
2014-03-31 $3,260
2013-12-31 $2,951
2013-09-30 $2,640
2013-06-30 $2,378
2013-03-31 $2,276
2012-12-31 $2,080
2012-09-30 $1,661
2012-06-30 $1,458
2012-03-31 $1,350
2011-12-31 $1,324
2011-09-30 $983
2011-06-30 $1,047
2011-03-31 $1,074
2010-12-31 $1,089
2010-09-30 $942
2010-06-30 $791
2010-03-31 $787
2009-12-31 $741
2009-09-30 $742
2009-06-30 $742
2009-03-31 $681
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $75.524B $13.117B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $151.412B 14.66
Bristol Myers Squibb (BMY) United States $119.764B 50.47
Gilead Sciences (GILD) United States $119.131B 21.58
Vertex Pharmaceuticals (VRTX) United States $113.704B 0.00
CSL (CSLLY) Australia $83.506B 0.00
GSK (GSK) United Kingdom $72.664B 8.41
Argenex SE (ARGX) Netherlands $39.526B 0.00
Alnylam Pharmaceuticals (ALNY) United States $35.339B 0.00
BioNTech SE (BNTX) Germany $29.047B 0.00
BeiGene (ONC) Cayman Islands $22.154B 0.00
Biogen (BIIB) United States $21.043B 9.04
Illumina (ILMN) United States $20.891B 76.14
Moderna (MRNA) United States $15.670B 0.00
Incyte (INCY) United States $14.202B 0.00
Insmed (INSM) United States $13.954B 0.00
Intra-Cellular Therapies (ITCI) United States $13.466B 0.00
Genmab (GMAB) Denmark $13.136B 19.27
Genmab (GNMSF) Denmark $12.927B 15.50
BioMarin Pharmaceutical (BMRN) United States $12.094B 28.08
Bio-Techne Corp (TECH) United States $11.413B 44.07
Vaxcyte (PCVX) United States $11.052B 0.00
Sarepta Therapeutics (SRPT) United States $11.028B 99.53
Exact Sciences (EXAS) United States $10.159B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Bio-Rad Laboratories (BIO.B) United States $10.013B 34.03
QIAGEN (QGEN) Netherlands $9.711B 19.98
Repligen (RGEN) United States $9.491B 123.65
Exelixis (EXEL) United States $9.413B 21.40
Roivant Sciences (ROIV) United Kingdom $8.102B 0.00
Ascendis Pharma (ASND) Denmark $7.741B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.513B 7.35
Blueprint Medicines (BPMC) United States $7.262B 0.00
Zealand Pharma (ZLDPF) Denmark $7.120B 0.00
Halozyme Therapeutics (HALO) United States $7.103B 16.04
Revolution Medicines (RVMD) United States $6.884B 0.00
Legend Biotech (LEGN) United States $6.593B 0.00
Telix Pharmaceuticals (TLX) Australia $6.223B 0.00
Nuvalent (NUVL) United States $6.076B 0.00
Guardant Health (GH) United States $5.887B 0.00
Cytokinetics (CYTK) United States $5.741B 0.00
TG Therapeutics (TGTX) United States $5.195B 0.00
Alkermes (ALKS) Ireland $5.106B 17.15
Axsome Therapeutics (AXSM) United States $5.095B 0.00
Krystal Biotech (KRYS) United States $4.495B 74.43
Verona Pharma American Depositary Share (VRNA) United Kingdom $4.383B 0.00
Scholar Rock Holding (SRRK) United States $3.984B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.922B 0.00
ADMA Biologics Inc (ADMA) United States $3.872B 40.95
Biohaven (BHVN) United States $3.815B 0.00
Avidity Biosciences (RNA) United States $3.808B 0.00
Alvotech (ALVO) Luxembourg $3.790B 0.00
Akero Therapeutics (AKRO) United States $3.769B 0.00
Viking Therapeutics (VKTX) United States $3.725B 0.00
Immunovant (IMVT) United States $3.701B 0.00
Apellis Pharmaceuticals (APLS) United States $3.666B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.517B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.515B 0.00
Arcellx (ACLX) United States $3.492B 0.00
PTC Therapeutics (PTCT) United States $3.488B 0.00
Denali Therapeutics (DNLI) United States $3.369B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.064B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.057B 23.55
Zai Lab (ZLAB) China $2.981B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.943B 0.00
Twist Bioscience (TWST) United States $2.939B 0.00
Vericel (VCEL) United States $2.911B 983.00
Amicus Therapeutics (FOLD) United States $2.866B 0.00
Merus (MRUS) Netherlands $2.852B 0.00
NovoCure (NVCR) Jersey $2.761B 0.00
SpringWorks Therapeutics (SWTX) United States $2.717B 0.00
Edgewise Therapeutics (EWTX) United States $2.691B 0.00
Kymera Therapeutics (KYMR) United States $2.552B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.482B 0.00
Vera Therapeutics (VERA) United States $2.402B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.378B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.333B 0.00
CG Oncology (CGON) United States $2.303B 0.00
Mesoblast (MESO) Australia $2.281B 0.00
Protagonist Therapeutics (PTGX) United States $2.277B 14.36
Ligand Pharmaceuticals (LGND) United States $2.247B 56.09
Certara (CERT) United States $2.236B 63.14
Janux Therapeutics (JANX) United States $2.231B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.214B 18.40
ImmunityBio (IBRX) United States $2.202B 0.00
Beam Therapeutics (BEAM) United States $2.145B 0.00
Bavarian Nordic (BVNRY) Denmark $2.119B 12.99
IDEAYA Biosciences (IDYA) United States $2.069B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.029B 0.00
Agios Pharmaceuticals (AGIO) United States $1.924B 0.00
NeoGenomics (NEO) United States $1.870B 0.00
Iovance Biotherapeutics (IOVA) United States $1.850B 0.00
WAVE Life Sciences (WVE) Singapore $1.817B 0.00
Apogee Therapeutics (APGE) United States $1.815B 0.00
Belite Bio (BLTE) United States $1.772B 0.00
Structure Therapeutics (GPCR) United States $1.761B 0.00
Geron (GERN) United States $1.747B 0.00
Dynavax Technologies (DVAX) United States $1.706B 99.85
Celldex Therapeutics (CLDX) United States $1.692B 0.00
MannKind (MNKD) United States $1.685B 43.64
Disc Medicine (IRON) United States $1.663B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.606B 0.00
Travere Therapeutics (TVTX) United States $1.596B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.583B 0.00
Viridian Therapeutics (VRDN) United States $1.539B 0.00
Galapagos (GLPG) Belgium $1.527B 0.00
Vir Biotechnology (VIR) United States $1.501B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.492B 0.00
Nurix Therapeutics (NRIX) United States $1.491B 0.00
Fortrea Holdings (FTRE) United States $1.480B 47.14
Novavax (NVAX) United States $1.411B 0.00
Praxis Precision Medicines (PRAX) United States $1.380B 0.00
MiMedx (MDXG) United States $1.330B 34.81
Day One Biopharmaceuticals (DAWN) United States $1.312B 0.00
ANI Pharmaceuticals (ANIP) United States $1.248B 17.01
Syndax Pharmaceuticals (SNDX) United States $1.215B 0.00
Liquidia Technologies (LQDA) United States $1.207B 0.00
Arvinas (ARVN) United States $1.206B 0.00
Pacira BioSciences (PCRX) United States $1.202B 11.32
Arcus Biosciences (RCUS) United States $1.191B 0.00
Myriad Genetics (MYGN) United States $1.142B 0.00
Adaptive Biotechnologies (ADPT) United States $1.138B 0.00
Spyre Therapeutics (SYRE) United States $1.126B 0.00
Gyre Therapeutics (GYRE) United States $1.074B 0.00
Intellia Therapeutics (NTLA) United States $1.031B 0.00
Cogent Biosciences (COGT) United States $1.027B 0.00
Zymeworks (ZYME) United States $1.006B 0.00
ArriVent BioPharma (AVBP) United States $0.978B 0.00
Replimune (REPL) United States $0.963B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.949B 0.00
AbCellera Biologics (ABCL) Canada $0.945B 0.00
89BIO (ETNB) United States $0.926B 0.00
Pharvaris (PHVS) Netherlands $0.922B 0.00
Oculis Holding AG (OCS) Switzerland $0.897B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.896B 0.00
GRAIL (GRAL) United States $0.896B 0.00
CureVac (CVAC) Germany $0.866B 7.04
Prothena (PRTA) Ireland $0.851B 0.00
Anavex Life Sciences (AVXL) United States $0.823B 0.00
Nuvation Bio (NUVB) United States $0.814B 0.00
Avid Bioservices (CDMO) United States $0.796B 0.00
Oric Pharmaceuticals (ORIC) United States $0.787B 0.00
Castle Biosciences (CSTL) United States $0.770B 137.45
UniQure (QURE) Netherlands $0.743B 0.00
Tyra Biosciences (TYRA) United States $0.741B 0.00
Cytek Biosciences (CTKB) United States $0.733B 0.00
Sana Biotechnology (SANA) United States $0.726B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.704B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.696B 0.00
LENZ Therapeutics (LENZ) United States $0.692B 0.00
Opthea (OPT) Australia $0.692B 0.00
Septerna (SEPN) United States $0.690B 0.00
CorMedix Inc (CRMD) United States $0.685B 0.00
Cullinan Therapeutics (CGEM) United States $0.655B 0.00
Pliant Therapeutics (PLRX) United States $0.654B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arbutus Biopharma (ABUS) United States $0.640B 0.00
Bicara Therapeutics (BCAX) United States $0.640B 0.00
Immatics (IMTX) Germany $0.636B 0.00
Dianthus Therapeutics (DNTH) United States $0.617B 0.00
CARGO Therapeutics (CRGX) United States $0.607B 0.00
Pharming Group (PHAR) Netherlands $0.600B 0.00
Kura Oncology (KURA) United States $0.598B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.589B 0.00
Emergent Biosolutions (EBS) United States $0.585B 0.00
Immunome (IMNM) United States $0.584B 0.00
Humacyte (HUMA) United States $0.574B 0.00
Rapport Therapeutics (RAPP) United States $0.572B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.569B 0.00
Stoke Therapeutics (STOK) United States $0.557B 0.00
Upstream Bio (UPB) United States $0.549B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.537B 0.00
AnaptysBio (ANAB) United States $0.530B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.528B 0.00
Erasca (ERAS) United States $0.520B 0.00
Mineralys Therapeutics (MLYS) United States $0.516B 0.00
Entrada Therapeutics (TRDA) United States $0.496B 8.34
GH Research (GHRS) Ireland $0.491B 0.00
MaxCyte (MXCT) United States $0.491B 0.00
Alpha Teknova (TKNO) United States $0.489B 0.00
Cartesian Therapeutics (RNAC) United States $0.489B 0.00
MeiraGTx Holdings (MGTX) United States $0.486B 0.00
Keros Therapeutics (KROS) United States $0.461B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.456B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.455B 0.00
ChromaDex (CDXC) United States $0.451B 590.00
Sage Therapeutics (SAGE) United States $0.448B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.448B 0.00
PureTech Health (PRTC) United States $0.446B 0.00
Eton Pharmaceuticals (ETON) United States $0.445B 0.00
Annexon (ANNX) United States $0.439B 0.00
Absci (ABSI) United States $0.430B 0.00
Compass Therapeutics (CMPX) United States $0.428B 0.00
Celcuity (CELC) United States $0.426B 0.00
Astria Therapeutics (ATXS) United States $0.421B 0.00
Aura Biosciences (AURA) United States $0.396B 0.00
Kamada (KMDA) Israel $0.387B 24.07
Allogene Therapeutics (ALLO) United States $0.386B 0.00
Precigen (PGEN) United States $0.381B 0.00
Revance Therapeutics (RVNC) United States $0.380B 0.00
Tectonic Therapeutic (TECX) United States $0.379B 0.00
Northwest Biotherapeutics (NWBO) United States $0.379B 0.00
REGENXBIO (RGNX) United States $0.373B 0.00
Abivax SA (ABVX) France $0.372B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.368B 0.00
Chimerix (CMRX) United States $0.366B 0.00
Codexis (CDXS) United States $0.364B 0.00
Prime Medicine (PRME) United States $0.361B 0.00
Olema Pharmaceuticals (OLMA) United States $0.356B 0.00
Kodiak Sciences (KOD) United States $0.355B 0.00
Terns Pharmaceuticals (TERN) United States $0.355B 0.00
MBX Biosciences (MBX) United States $0.343B 0.00
Tango Therapeutics (TNGX) United States $0.334B 0.00
EnGene Holdings (ENGN) Canada $0.327B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.326B 0.00
XOMA Royalty (XOMA) United States $0.312B 0.00
Neumora Therapeutics (NMRA) United States $0.312B 0.00
Alumis (ALMS) United States $0.308B 0.00
ATyr Pharma (ATYR) United States $0.305B 0.00
Zenas BioPharma (ZBIO) United States $0.305B 0.00
Voyager Therapeutics (VYGR) United States $0.302B 7.77
Prima BioMed (IMMP) Australia $0.298B 0.00
Trevi Therapeutics (TRVI) United States $0.297B 0.00
Rezolute (RZLT) United States $0.293B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.283B 0.00
Design Therapeutics (DSGN) United States $0.280B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.275B 0.00
ITeos Therapeutics (ITOS) United States $0.274B 0.00
Verastem (VSTM) United States $0.268B 0.00
Contineum Therapeutics (CTNM) United States $0.267B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.264B 0.00
AC Immune (ACIU) Switzerland $0.261B 0.00
Urogen Pharma (URGN) United States $0.258B 0.00
Semper Paratus Acquisition (TVGN) United States $0.254B 0.00
C4 Therapeutics (CCCC) United States $0.253B 0.00
Atea Pharmaceuticals (AVIR) United States $0.253B 0.00
Benitec Biopharma (BNTC) United States $0.252B 0.00
DiaMedica Therapeutics (DMAC) United States $0.252B 0.00
BioStem Technologies (BSEM) $0.249B 21.99
Anika Therapeutics (ANIK) United States $0.248B 0.00
Abeona Therapeutics (ABEO) United States $0.237B 0.00
Monopar Therapeutics (MNPR) United States $0.237B 0.00
Sangamo Therapeutics (SGMO) United States $0.236B 0.00
Third Harmonic Bio (THRD) United States $0.234B 0.00
Amarin (AMRN) Ireland $0.232B 0.00
Neurogene (NGNE) United States $0.230B 0.00
Lifecore Biomedical (LFCR) United States $0.224B 0.00
Foghorn Therapeutics (FHTX) United States $0.221B 0.00
Nautilus Biotechnology (NAUT) United States $0.221B 0.00
Fulcrum Therapeutics (FULC) United States $0.220B 0.00
Candel Therapeutics (CADL) United States $0.216B 0.00
Ocugen (OCGN) United States $0.216B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.214B 0.00
TuHURA Biosciences (HURA) United States $0.214B 0.00
Molecular Partners AG (MOLN) Switzerland $0.211B 0.00
Gossamer Bio (GOSS) United States $0.208B 0.00
Compugen (CGEN) Israel $0.208B 116.50
Orchestra BioMed Holdings (OBIO) United States $0.206B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.203B 0.00
INmune Bio (INMB) United States $0.201B 0.00
ACELYRIN, INC (SLRN) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
Adocia (ADOCY) France $0.185B 0.00
Inhibrx Biosciences (INBX) United States $0.178B 0.00
BioAge Labs (BIOA) United States $0.178B 0.00
Adherex Technologies (FENC) United States $0.178B 0.00
Cardiff Oncology (CRDF) United States $0.176B 0.00
Greenwich LifeSciences (GLSI) United States $0.174B 0.00
Instil Bio (TIL) United States $0.172B 0.00
Actuate Therapeutics (ACTU) United States $0.172B 0.00
ScPharmaceuticals (SCPH) United States $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.163B 0.00
Alector (ALEC) United States $0.161B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.160B 0.00
Nkarta (NKTX) United States $0.158B 0.00
Sutro Biopharma (STRO) United States $0.155B 0.00
Biomea Fusion (BMEA) United States $0.153B 0.00
Puma Biotechnology (PBYI) United States $0.151B 6.40
Palvella Therapeutics (PVLA) United States $0.149B 0.00
Fate Therapeutics (FATE) United States $0.149B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.149B 0.00
Akoya Biosciences (AKYA) United States $0.149B 0.00
Innate Pharma S.A (IPHA) France $0.148B 0.00
Coherus BioSciences (CHRS) United States $0.141B 0.00
Genelux (GNLX) United States $0.141B 0.00
Kyverna Therapeutics (KYTX) United States $0.140B 0.00
Checkpoint Therapeutics (CKPT) United States $0.139B 0.00
Black Diamond Therapeutics (BDTX) United States $0.138B 0.00
Seres Therapeutics (MCRB) United States $0.137B 0.00
Seer (SEER) United States $0.137B 0.00
Ventyx Biosciences (VTYX) United States $0.137B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.135B 0.00
TScan Therapeutics (TCRX) United States $0.133B 0.00
Solid Biosciences (SLDB) United States $0.133B 0.00
Bright Minds Biosciences (DRUG) United States $0.132B 0.00
InflaRx (IFRX) Germany $0.132B 0.00
Artiva Biotherapeutics (ARTV) United States $0.131B 0.00
Climb Bio (CLYM) United States $0.130B 0.00
2seventy Bio (TSVT) United States $0.128B 0.00
Cidara Therapeutics (CDTX) United States $0.126B 0.00
X4 Pharmaceuticals (XFOR) United States $0.125B 0.00
Sagimet Biosciences (SGMT) United States $0.124B 0.00
Nuvectis Pharma (NVCT) United States $0.123B 0.00
Caribou Biosciences (CRBU) United States $0.121B 0.00
Renovaro (RENB) United States $0.121B 0.00
Inventiva S.A (IVA) France $0.121B 0.00
Cabaletta Bio (CABA) United States $0.116B 0.00
Alto Neuroscience (ANRO) United States $0.114B 0.00
Zura Bio (ZURA) United States $0.113B 0.00
Editas Medicine (EDIT) United States $0.111B 0.00
XBiotech (XBIT) United States $0.110B 0.00
Scilex Holding (SCLX) United States $0.109B 0.00
TELA Bio (TELA) United States $0.109B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.107B 0.00
Skye Bioscience (SKYE) United States $0.104B 0.00
Elicio Therapeutics (ELTX) United States $0.104B 0.00
Elutia (ELUT) United States $0.103B 0.00
Alpha Cognition (ACOG) Canada $0.101B 0.00
CAMP4 Therapeutics (CAMP) United States $0.100B 0.00
Invizyne Technologies (IZTC) United States $0.099B 0.00
MediciNova (MNOV) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
HilleVax (HLVX) United States $0.097B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.097B 0.00
Vor Biopharma (VOR) $0.095B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.094B 0.00
Inozyme Pharma (INZY) United States $0.091B 0.00
Adverum Biotechnologies (ADVM) United States $0.091B 0.00
23andMe Holding (ME) United States $0.090B 0.00
Vigil Neuroscience (VIGL) United States $0.090B 0.00
Immunic (IMUX) United States $0.089B 0.00
IGM Biosciences (IGMS) United States $0.087B 0.00
DBV Technologies S.A (DBVT) France $0.087B 0.00
Jasper Therapeutics (JSPR) United States $0.087B 0.00
Aligos Therapeutics (ALGS) United States $0.086B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
Citius Oncology (CTOR) United States $0.086B 0.00
I-Mab (IMAB) China $0.086B 0.00
Entera Bio (ENTX) Israel $0.085B 0.00
Cue Biopharma (CUE) United States $0.085B 0.00
Agenus (AGEN) United States $0.085B 0.00
Cellectis S.A (CLLS) France $0.084B 0.00
Tenaya Therapeutics (TNYA) United States $0.083B 0.00
Adagene (ADAG) China $0.082B 0.00
BioHarvest Sciences (BHST) Canada $0.081B 0.00
Rani Therapeutics Holdings (RANI) United States $0.080B 0.00
VistaGen Therapeutics (VTGN) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.078B 0.00
ALX Oncology Holdings (ALXO) United States $0.077B 0.00
Adlai Nortye (ANL) Cayman Islands $0.076B 0.00
Aerovate Therapeutics (AVTE) United States $0.074B 0.00
Adicet Bio (ACET) United States $0.074B 0.00
Bluebird Bio (BLUE) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Theratechnologies (THTX) Canada $0.073B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.073B 0.00
Mersana Therapeutics (MRSN) United States $0.073B 0.00
Ikena Oncology (IKNA) United States $0.072B 0.00
Quince Therapeutics (QNCX) United States $0.072B 0.00
Aadi Bioscience (AADI) United States $0.071B 0.00
ZIVO Bioscience (ZIVO) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
Annovis Bio (ANVS) United States $0.067B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.067B 0.00
BGM Group (BGM) China $0.066B 0.00
Earth Science Tech (ETST) United States $0.065B 0.00
CytomX Therapeutics (CTMX) United States $0.064B 4.82
Oncobiologics (OTLK) United States $0.064B 0.00
Applied Therapeutics (APLT) United States $0.063B 0.00
Shattuck Labs (STTK) United States $0.063B 0.00
IO Biotech (IOBT) Denmark $0.062B 0.00
Kronos Bio (KRON) United States $0.062B 0.00
PepGen (PEPG) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.060B 0.00
Immuneering (IMRX) United States $0.059B 0.00
Oncolytics Biotech (ONCY) Canada $0.058B 0.00
Abpro Holdings (ABP) United States $0.058B 0.00
Generation Bio (GBIO) United States $0.057B 0.00
PDS Biotechnology (PDSB) United States $0.057B 0.00
Immix Biopharma (IMMX) United States $0.057B 0.00
FibroBiologics (FBLG) United States $0.055B 0.00
Boundless Bio (BOLD) United States $0.055B 0.00
Rein Therapeutics (RNTX) United States $0.054B 0.00
KALA BIO (KALA) United States $0.054B 0.00
Connect Biopharma Holdings (CNTB) United States $0.054B 0.00
Inovio Pharmaceuticals (INO) United States $0.053B 0.00
Ovid Therapeutics (OVID) United States $0.053B 0.00
Celularity (CELU) United States $0.051B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.049B 0.00
Lantern Pharma (LTRN) United States $0.049B 0.00
Repare Therapeutics (RPTX) Canada $0.049B 0.00
Fortress Biotech (FBIO) United States $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.047B 0.00
Spero Therapeutics (SPRO) United States $0.047B 12.28
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.046B 0.00
Invivyd (IVVD) United States $0.046B 0.00
VTv Therapeutics (VTVT) United States $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Estrella Immunopharma (ESLA) United States $0.042B 0.00
Rapt Therapeutics (RAPT) United States $0.041B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.040B 0.00
Q32 Bio (QTTB) United States $0.039B 0.00
Clene (CLNN) United States $0.039B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.038B 0.00
UNITY Biotechnology (UBX) United States $0.038B 0.00
Precision BioSciences (DTIL) United States $0.038B 0.00
Elevation Oncology (ELEV) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Rallybio (RLYB) United States $0.036B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Passage Bio (PASG) United States $0.036B 0.00
CalciMedica (CALC) United States $0.035B 0.00
Grace Therapeutics (GRCE) Canada $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.035B 0.00
Opus Genetics (IRD) United States $0.034B 0.00
Intensity Therapeutics (INTS) United States $0.033B 0.00
Cadrenal Therapeutics (CVKD) United States $0.033B 0.00
Enzo Biochem (ENZ) United States $0.033B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Cognition Therapeutics (CGTX) United States $0.032B 0.00
Xilio Therapeutics (XLO) United States $0.031B 0.00
Medicus Pharma (MDCX) Canada $0.031B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.030B 0.00
Chemomab Therapeutics (CMMB) Israel $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Pulmatrix (PULM) United States $0.029B 0.00
Beyond Air (XAIR) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.028B 0.00
Exicure (XCUR) United States $0.028B 0.00
Curis (CRIS) United States $0.027B 0.00
Omega Therapeutics (OMGA) United States $0.027B 0.00
Femasys (FEMY) United States $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.026B 0.00
Gelteq (GELS) Australia $0.026B 0.00
LakeShore Biopharma (LSB) China $0.025B 0.00
Pluri (PLUR) Israel $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
Equillium (EQ) United States $0.024B 0.00
Longeveron (LGVN) United States $0.023B 0.00
Cara Therapeutics (CARA) United States $0.023B 0.00
Allakos (ALLK) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
NextCure (NXTC) United States $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.022B 0.00
Leap Therapeutics (LPTX) United States $0.022B 0.00
NKGen Biotech (NKGN) United States $0.022B 0.00
Forte Biosciences (FBRX) United States $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
Tenax Therapeutics (TENX) United States $0.021B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
Senti Biosciences (SNTI) United States $0.021B 0.00
Athira Pharma (ATHA) United States $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Aprea Therapeutics (APRE) United States $0.020B 0.00
IN8bio (INAB) United States $0.019B 0.00
Bolt Biotherapeutics (BOLT) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
OnKure Therapeutics (OKUR) United States $0.018B 0.00
BRIACELL THERAP (BCTX) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
BioXcel Therapeutics (BTAI) United States $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
Biorestorative Therapies (BRTX) United States $0.016B 0.00
Affimed (AFMD) Germany $0.016B 0.00
Dogwood Therapeutics (DWTX) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Spruce Biosciences (SPRB) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
CervoMed (CRVO) United States $0.014B 0.00
Imunon (IMNN) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
BioAffinity Technologies (BIAF) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Aptose Biosciences (APTO) Canada $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Mainz Biomed (MYNZ) Germany $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
HCW Biologics (HCWB) United States $0.010B 0.00
Carmell (CTCX) United States $0.010B 0.00
Apollomics (APLM) United States $0.009B 0.00
Ensysce Biosciences (ENSC) United States $0.009B 0.00
Hoth Therapeutics (HOTH) United States $0.009B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.008B 0.00
Ocean Biomedical (OCEA) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Silo Pharma (SILO) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Novogen (KZIA) Australia $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Allarity Therapeutics (ALLR) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Quantum Biopharma (QNTM) Canada $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Organovo Holdings (ONVO) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Syros Pharmaceuticals (SYRS) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Eyenovia (EYEN) United States $0.004B 0.00
Evaxion Biotech (EVAX) Denmark $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Vincerx Pharma (VINC) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
NAYA Biosciences (NAYA) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00